Medicine & Health

Nearly 70% of Missouri schools tested showed traces of potent synthetic opioids, as a new iHeard poll finds most St. Louis residents are unaware of the threat.

WashU Medicine researchers have developed a software, De-ID, that flags sensitive information in data collected through focus groups, surveys and interviews. It allows for easy removal of such details to enable safe sharing.

New research from WashU Medicine adds to growing evidence that helping brain cells break down and eliminate their own cellular waste is a promising treatment strategy for a variety of neurodegenerative diseases.

The CONNECT program at WashU Medicine streamlines clinical services to provide timely, research-based mental health care that helps teens who have experienced trauma and suicide ideation.

Research in Jon Silva’s lab at WashU McKelvey Engineering highlights the importance of genetic testing for precision medicine.

Developed by WashU Medicine researchers and licensed to WashU startup Wugen, the immunotherapy is designed to treat rare and aggressive types of blood cancer.

Sarah Ackerman, at WashU Medicine, has been named a winner of the Maximizing Innovation in Neuroscience Discovery Prize by the Pershing Square Foundation. 

Eleven WashU faculty members are among the new fellows selected by the American Association for the Advancement of Science, one of the most distinct honors in the scientific community.

WashU Medicine researchers found that stopping GLP-1 drugs such as semaglutide and tirzepatide — even temporarily — elevates the risk of heart attack, stroke and death compared to staying on the medication continuously.

Shrinking public health funding, workforce shortages and misinformation are straining systems. A WashU forum explores how leaders can safeguard preparedness and sustain population health systems.